Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-16

FDA Approved: DESVENLAFAXINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for desvenlafaxine submitted by Actavis Pharma, Inc., indicating an approved update to the product's labeling or manufac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desvenlafaxine (Desvenlafaxine)

Snippet

SUPPL AP for DESVENLAFAXINE (DESVENLAFAXINE)